Cancer

Showing NaN - NaN of 105

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer Trial in London (PET Scan)

Unknown status
  • Cancer
  • PET Scan
  • London, United Kingdom
    Barts Health NHS Trust
Feb 24, 2020

Lymphoma, Cancer Trial in Sarasota, Nashville, London (Romidepsin)

Completed
  • Lymphoma
  • Cancer
  • Sarasota, Florida
  • +2 more
Nov 14, 2019

Liver Resection, Cancer Trial in London (Radiofrequency assisted liver partition with portal vein ligation (RALPP), Portal vein

Completed
  • Liver Resection
  • Cancer
  • Radiofrequency assisted liver partition with portal vein ligation (RALPP)
  • Portal vein embolization (PVE)
  • London, United Kingdom
    Hammersmith Hospital
Oct 18, 2019

Cancer Trial in London (MR Linac)

Recruiting
  • Cancer
  • MR Linac
  • London, United Kingdom
    Royal Marsden NHSFT
Nov 6, 2019

Cancer Trial in Worldwide (Lapatinib, Capecitabine, Octreotide)

Terminated
  • Cancer
  • Olomouc, Czechia
  • +16 more
May 2, 2019

Cancer Trial in Worldwide (GSK2118436, GSK1120212, Other approved anti-cancer agent)

Completed
  • Cancer
  • Goodyear, Arizona
  • +43 more
Mar 20, 2019

Cancer, Advanced Solid Malignancies Trial in Worldwide (AZD4547)

Terminated
  • Cancer
  • Advanced Solid Malignancies
  • Stanford, California
  • +28 more
Nov 30, 2018

Cancer, GI Cancer Trial in Sutton, London (Domatinostat, Avelumab)

Unknown status
  • Cancer
  • GI Cancer
  • Sutton, Surrey, United Kingdom
  • +1 more
Feb 1, 2019

Patient-specific 'Tumouroids' as Personalised Treatment

Completed
  • Cancer
  • Questionnaires, interviews and or tissue donation
  • London, United Kingdom
  • +1 more
Jan 22, 2019

Venous Thromboembolism, Cancer Trial in Canada (Apixaban, Placebo drug)

Completed
  • Venous Thromboembolism
  • Cancer
  • Vancouver, British Columbia, Canada
  • +13 more
Nov 19, 2018

Cancer, Carcinoma, Castrate-Resistant Prostate Cancer Trial in Worldwide (Denosumab)

Completed
  • Cancer
  • +4 more
  • Huntsville, Alabama
  • +73 more
Oct 17, 2018

Cancer, Melanoma, Breast Cancer Trial in Worldwide (LTX-315 consecutive lesions, LTX-315, LTX-315 + ipilimumab)

Completed
  • Cancer
  • +5 more
  • LTX-315 consecutive lesions
  • +3 more
  • Bruxelles, Belgium
  • +13 more
Oct 2, 2018

Cancer, Cardiovascular Diseases Trial in London (Hyperpolarised MRI)

Unknown status
  • Cancer
  • Cardiovascular Diseases
  • Hyperpolarised MRI
  • London, United Kingdom
    University College London
Sep 26, 2018

Cancer Trial in Korea, Republic of, United Kingdom, United States (GSK2636771)

Completed
  • Cancer
  • New Haven, Connecticut
  • +7 more
Jul 20, 2018

Development of Photoacoustic Tomography

Unknown status
  • Cancer
  • Cardiovascular Diseases
  • Photoacoustic tomography
  • London, United Kingdom
    University College London Hospital
Apr 17, 2018

Cancer Trial in London (Acupuncture)

Completed
  • Cancer
  • Acupuncture
  • London, United Kingdom
    University College London Hospitals Cancer Clinical Trials Unit
Feb 7, 2018

UsingElectronic Nose to Predict Gastrointestinal Consequences of

Unknown status
  • Cancer
  • +2 more
  • Cohort Observation
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Jan 29, 2018

GI Consequences Economic Evaluation

Completed
  • Cancer
  • GIANT Completed patient
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Jan 29, 2018

Cancer, Colon Cancer, Colorectal Cancer Trial in Worldwide (Pegfilgrastim, Placebo, Bevacizumab)

Completed
  • Cancer
  • +7 more
  • Muscle Shoals, Alabama
  • +153 more
Dec 5, 2017

"Focusing on Cancers Chemotherapys' Untreated Symptoms"

Completed
  • Cancer
    • London, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Nov 21, 2017

    Cancer Trial in Australia, United Kingdom, United States (Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily

    Completed
    • Cancer
    • Dabrafenib 150 mg twice a day (BID)
    • +2 more
    • Goodyear, Arizona
    • +5 more
    Nov 10, 2017

    Cancer Trial in Australia, United Kingdom, United States (GSK2118436 75 mg, Placebo)

    Completed
    • Cancer
    • GSK2118436 75 mg
    • Placebo
    • Scottsdale, Arizona
    • +7 more
    Nov 8, 2017